HSD65 Influence of Research Findings and Systems on Minimal Residual Disease (MRD) Testing and FLT3 Inhibitor Maintenance Prescribing Behavior Post-Transplant for Patients with Acute Myeloid Leukemia (AML) of U.S. Oncologists
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.1288
https://www.valueinhealthjournal.com/article/S1098-3015(24)01403-7/fulltext
Title :
HSD65 Influence of Research Findings and Systems on Minimal Residual Disease (MRD) Testing and FLT3 Inhibitor Maintenance Prescribing Behavior Post-Transplant for Patients with Acute Myeloid Leukemia (AML) of U.S. Oncologists
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01403-7&doi=10.1016/j.jval.2024.03.1288
First page :
Section Title :
Open access? :
No
Section Order :
10682